Prasad S C, Thraves P J, Bhatia K G, Smulson M E, Dritschilo A
Department of Radiation Medicine, Georgetown University Medical Center, Washington, DC 20007.
Cancer Res. 1990 Jan 1;50(1):38-43.
Ewing's sarcoma (ES) is a highly malignant childhood bone tumor and is considered curable by moderate doses of radiotherapy. The addition of chemical inhibitors of the activity of the nuclear enzyme poly(adenosine diphosphate ribose) [poly(ADPR)] polymerase to ES cells in culture results in increased cell killing, a phenomenon called "inhibitor sensitization." Since poly(ADPR) polymerase is thought to be associated with DNA repair, it has been suggested that ES cells and other inhibitor-sensitized cells may have a reduced capacity for polymer synthesis resulting in deficient postirradiation recovery. We present here the unexpected observation that in comparison to other cell lines tested, ES cells exhibit a high enzyme activity, higher constitutive levels of the protein, and elevated levels of its mRNA transcript for poly(ADPR) polymerase. No gross amplifications or rearrangements of the gene were observed; however, regulation of poly(ADPR) polymerase in these tumor cells takes place at the level of the gene transcript.
尤因肉瘤(ES)是一种高度恶性的儿童骨肿瘤,被认为中等剂量放疗即可治愈。在培养的ES细胞中添加核酶聚(二磷酸腺苷核糖)[聚(ADPR)]聚合酶活性的化学抑制剂会导致细胞杀伤增加,这种现象称为“抑制剂致敏”。由于聚(ADPR)聚合酶被认为与DNA修复有关,因此有人提出ES细胞和其他抑制剂致敏细胞可能具有降低的聚合物合成能力,从而导致辐射后恢复不足。我们在此展示了一个意外的观察结果,即与测试的其他细胞系相比,ES细胞表现出高酶活性、该蛋白更高的组成水平及其聚(ADPR)聚合酶mRNA转录本的升高水平。未观察到该基因的明显扩增或重排;然而,这些肿瘤细胞中聚(ADPR)聚合酶的调节发生在基因转录水平。